Business
Investor Presentation
Investor Presentation.
About this update from Ixico Plc
[{"type":"text","content":"\n \n \n \n \n 16 May 2022 \n \n \n \n \n \n IXICO plc\n \n \n \n \n \n \n \n \n \n (\"IXICO\", the \"Company\" or the \"Group\")\n \n \n \n \n \n \n \n \n \n Half-year results investor presentation\n \n \n \n \n \n \n \n \n IXICO plc (AIM: IXI), the\n medical imaging advanced analytics company delivering intelligent insights in neuroscience\n today announces the date of its investor presentation to accompany its half-year results\n .\n \n \n \n \n \n \n Investor presentation\n \n \n \n \n \n \n \n \n Giulio Cerroni (CEO) and Grant Nash (CFO) will provide a live presentation relating to IXICO's half-year results via the Investor Meet Company platform on 24th May 2022 at 4.30pm BST.\n \n \n \n \n \n The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.\n \n \n Investors can sign up to Investor Meet Company for free and add to meet IXICO PLC via:\n \n \n https://www.investormeetcompany.com/ixico-plc/register-investor\n \n \n \n \n Investors who already follow IXICO PLC on the Investor Meet Company platform will automatically be invited.\n \n \n \n \n \n \n \n \n \n \n \n \n \n For further information please contact:\n \n \n \n \n \n \n \n \n \n \n \n \n \n IXICO plc\n \n \n \n \n \n +44 (0)20 3763 7499\n \n \n \n \n \n \n Giulio Cerroni, Chief Executive Officer\n \n \n Grant Nash, Chief Financial Officer\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Cenkos Securities PLC (Nominated adviser and sole broker)\n \n \n \n \n \n +44 (0)20 7397 8900\n \n \n \n \n \n \n Giles Balleny / Max Gould (Corporate Finance)\n \n \n \n \n \n \n \n \n \n \n \n \n \n Michael F Johnson / Tamar Cranford-Smith (Sales)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n About IXICO\n \n \n \n IXICO is dedicated to delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Huntington's disease, Pa...